Novel prognostic biomarkers in colorectal cancer

Research output: Contribution to journalArticlepeer-review


The main predictor of outcome of patients with colorectal cancer (CRC) remains the TNM staging system. Biomarkers, i.e. biological indicators of disease progression or of responsiveness to a pharmacological intervention, are expected to be of help in the management of CRC. Despite high expectations, biomarkers have not entered into clinical practice due to contradictory results of large-scale studies and to some complexity in data interpretation. Here we briefly review the main genetic and immunological changes that have been considered potential CRC biomarkers and that might be considered for further testing aimed at clinical use, at least in specific disease settings.

Original languageEnglish
Pages (from-to)296-303
Number of pages8
JournalDigestive Diseases
Issue number3
Publication statusPublished - Jun 2012


  • Biomarkers
  • Colorectal cancer
  • TNM staging

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Novel prognostic biomarkers in colorectal cancer'. Together they form a unique fingerprint.

Cite this